Maguire; Robert John
Patent Applications and Registrations
Patent applications and USPTO patent grants for Maguire; Robert John.The latest application filed is for "peptide conjugates of cytotoxins as therapeutics".
- Maguire; Robert John - New Haven CT
- Maguire; Robert John - East Lyme CT
- Maguire; Robert John - Groton CT
- Maguire, Robert John - US
- Maguire; Robert John - Sandwich GB
| Patent | Date |
|---|---|
| Peptide Conjugates Of Cytotoxins As Therapeutics App 20210009719 - Marshall; Daniel Richard ; et al. | 2021-01-14 |
| Peptide Conjugates Of Microtubule-targeting Agents As Therapeutics App 20210009536 - Marshall; Daniel Richard ; et al. | 2021-01-14 |
| Cycloalkylamino acid derivatives Grant 7,671,043 - Maguire March 2, 2 | 2010-03-02 |
| Cycloalkylamino Acid Derivatives App 20070270438 - Bhattacharya; Samit Kumar ; et al. | 2007-11-22 |
| Pharmaceuticals Grant 7,045,653 - Dack , et al. May 16, 2 | 2006-05-16 |
| 3-(imidazolyl)-2-alkoxypropanoic acids Grant 6,958,402 - Allerton , et al. October 25, 2 | 2005-10-25 |
| Novel pharmaceuticals App 20050075392 - Dack, Kevin Neil ; et al. | 2005-04-07 |
| 3-(imidazolyl)-2-alkoxypropanoic acids App 20040254164 - Allerton, Charlotte Moira Norfor ; et al. | 2004-12-16 |
| 3-(imidazolyl)-2-alkoxypropanoic acids Grant 6,713,496 - Allerton , et al. March 30, 2 | 2004-03-30 |
| 3-(Imidazolyl)-2-alkoxypropanoic acids App 20030199522 - Allerton, Charlotte Moira Norfor ; et al. | 2003-10-23 |
| Heterocyclic compounds as inhibitors of rotomase enzymes Grant 6,610,707 - Bull , et al. August 26, 2 | 2003-08-26 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 